Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Moreno

Showing results (111-120 of 194) with videos related to

Pageof 20
Sort By:
Plos One|January 6, 2017
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic ResponseTarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Gut|March 4, 2015
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitisLaurent Dubuquoy, Alexandre Louvet, Guillaume Lassailly, et al.
Journal of Viral Hepatitis|January 23, 2025
Severe Liver-Related Outcomes in Patients With Hepatitis Delta: Results From a Multi-Ethnic Multicenter Long-Term Follow-Up StudyArno Furquim d'Almeida, Erwin Ho, Liesbeth Govaerts, et al.
European Journal of Gastroenterology & Hepatology|July 16, 2010
Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patientsRéginald Brenard, Xavier Chapaux, Pierre Deltenre, et al.
Gastroenterology|December 23, 2009
Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 controlSébastien Dharancy, Mathilde Body-Malapel, Alexandre Louvet, et al.
Surgical Oncology|October 22, 2019
Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in BelgiumHelena Degroote, Eduard Callebout, Samuele Iesari, et al.
Journal of Gastroenterology and Hepatology|November 5, 2020
Biliary cast syndrome after liver transplantation: A cholangiographic evolution studyArnaud Lemmers, Martina Pezzullo, Alia Hadefi, et al.
Journal of Hepatology|December 15, 2010
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver diseaseEric Trépo, Andrej Potthoff, Pierre Pradat, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis CStefan Zeuzem, Peter Buggisch, Kosh Agarwal, et al.
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.
Pageof 20

Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
Plos One|January 6, 2017
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic ResponseTarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Gut|March 4, 2015
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitisLaurent Dubuquoy, Alexandre Louvet, Guillaume Lassailly, et al.
Journal of Viral Hepatitis|January 23, 2025
Severe Liver-Related Outcomes in Patients With Hepatitis Delta: Results From a Multi-Ethnic Multicenter Long-Term Follow-Up StudyArno Furquim d'Almeida, Erwin Ho, Liesbeth Govaerts, et al.
European Journal of Gastroenterology & Hepatology|July 16, 2010
Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patientsRéginald Brenard, Xavier Chapaux, Pierre Deltenre, et al.
Gastroenterology|December 23, 2009
Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 controlSébastien Dharancy, Mathilde Body-Malapel, Alexandre Louvet, et al.
Surgical Oncology|October 22, 2019
Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in BelgiumHelena Degroote, Eduard Callebout, Samuele Iesari, et al.
Journal of Gastroenterology and Hepatology|November 5, 2020
Biliary cast syndrome after liver transplantation: A cholangiographic evolution studyArnaud Lemmers, Martina Pezzullo, Alia Hadefi, et al.
Journal of Hepatology|December 15, 2010
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver diseaseEric Trépo, Andrej Potthoff, Pierre Pradat, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis CStefan Zeuzem, Peter Buggisch, Kosh Agarwal, et al.
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.
Pageof 20